The Breast Cancer Channel

Explore the latest updates, including expert interviews and features

The Breast Cancer Channel on VJOncology is supported by Gilead and Seagen. These supporters have no influence over the production of the content.

Latest Videos Breast Cancer Sessions Topics SABCS 2021 Conferences Features Editorial Board

Welcome to the Breast Cancer Channel!

VJOncology brings you the latest updates in the field of breast cancer, keeping you up-to-date with the most exciting developments with video interviews, podcasts, and roundtable discussions, and more.

Reporting from key international congresses alongside our expert Editorial Board, catch up on the key advances in breast cancer, including the use of novel treatment approaches, key trial updates as well as the emerging role of treatment de-escalation.

Breast Cancer Videos by Topic

Immuno-Oncology
Surgery
Trial Updates
Molecular Profiling
Screening
4:28
Pertuzumab, trastuzumab and cyclophosphamide in older patients with HER2+ breast cancer
Thomas Meyskens • 30 May 2022
0:54
Breast cancer highlights at ASCO 2022
Philippe Georges Aftimos • 5 Jun 2022
1:02
Key takeaways from ASCO 2022
Pat W. Whitworth • 6 Jun 2022
1:46
Exploratory analysis of KEYNOTE-522: EFS after neoadjuvant pembro + chemo Vs chemo for early TNBC
Lajos Pusztai • 6 Jun 2022
View All Videos
5:26
Important considerations when combining chest wall irradiation with mastectomy
Icro Meattini • 23 May 2022
1:03
Remaining questions on the use of neoadjuvant pembrolizumab in early TNBC following KEYNOTE-522
Lajos Pusztai • 6 Jun 2022
6:23
Stratifying patients with breast cancer by a 7-gene assay for endocrine therapy
Pat W. Whitworth • 6 Jun 2022
1:18
eRAPID: electronic self-reporting of adverse events for patients undergoing cancer treatment
Galina Velikova • 3 May 2022
View All Videos
3:01
Assessing elacestrant in ctDNA-positive patients with ER+ breast cancer
Thomas Meyskens • 30 May 2022
4:28
Pertuzumab, trastuzumab and cyclophosphamide in older patients with HER2+ breast cancer
Thomas Meyskens • 30 May 2022
2:35
AMEERA-6: Amcenestrant, a novel SERD, in HR+ breast cancer
Thomas Meyskens • 30 May 2022
1:08
DESTINY-Breast04: A ground-breaking trial in HER2-low breast cancer
Thomas Meyskens • 30 May 2022
View All Videos
2:06
Association of 80 gene signature reclassification with neoadjuvant treatment response in BC
Pat W. Whitworth • 6 Jun 2022
1:03
Remaining questions on the use of neoadjuvant pembrolizumab in early TNBC following KEYNOTE-522
Lajos Pusztai • 6 Jun 2022
4:18
ASCO 2022: DESTINY-Breast04, PALOMA-2, rEECur
Abhenil Mittal • 6 Jun 2022
2:21
ADCs for the treatment of HER2-low breast cancer
Paolo Tarantino • 5 Jun 2022
View All Videos
6:29
Should polygenic risk scores be used to risk-stratify the use of PSA-screening in prostate cancer?
Andrew Vickers • 11 May 2022
1:39
Using single cell technologies to identify biomarkers for breast cancer patient outcomes
Sofia Mastoraki • 11 Apr 2022
0:34
Unanswered questions in DCIS progression
Tanjina Kader • 11 Apr 2022
0:38
Clinical implications for recurrent nonclonal primary DCIS
Tanjina Kader • 11 Apr 2022
View All Videos

Breast Cancer Videos by Conference

ASCO 2022
ESMO Breast 2022
SABCS 2021
ESMO 2021
ASCO 2021
ESMO Breast 2021
3:01
Assessing elacestrant in ctDNA-positive patients with ER+ breast cancer
Thomas Meyskens • 30 May 2022
4:28
Pertuzumab, trastuzumab and cyclophosphamide in older patients with HER2+ breast cancer
Thomas Meyskens • 30 May 2022
2:35
AMEERA-6: Amcenestrant, a novel SERD, in HR+ breast cancer
Thomas Meyskens • 30 May 2022
1:08
DESTINY-Breast04: A ground-breaking trial in HER2-low breast cancer
Thomas Meyskens • 30 May 2022
View All Videos
0:31
Exciting developments in ADCs for BC presented at ESMO Breast 2022
Rupert Bartsch • 5 May 2022
1:23
Exploring myeloid cells to reverse the hormone-mediated microenvironemnt of luminal breast cancer
Céline Blaye • 4 May 2022
0:27
Immunotherapy insights from ESMO Breast 2022
Céline Blaye • 4 May 2022
1:27
PRADA: evaluating radiotherapy before deep inferior flap reconstruction
Philip Poortmans • 3 May 2022
View All Videos
3:44
Correlation of Trop-2 expression with clinicopathological characteristics and outcome in TNBC
Hava Izci • 10 Dec 2021
3:50
The role of SOFT and TEXT in treatment decision making for patients with breast cancer
Meredith M. Regan • 12 Dec 2021
2:01
ASCENT: sacituzumab govitecan outperforms chemo in Black patients with TNBC
Lisa A. Carey • 7 Dec 2021
6:54
Key clinical trials investigating immunotherapy in HER2+ and HR+ breast cancer
Giuseppe Curigliano • 9 Dec 2021
View All Videos
2:06
NGS multi-panel gene testing for newly diagnosed patients with metastatic breast cancer
Evandro de Azambuja • 18 Sep 2021
4:40
AMEERA-1 updates: amcenestrant plus palbociclib for patients with ER+/HER2– advanced breast cancer
Mario Campone • 30 Sep 2021
2:46
Prognostic impact of immune interactions in patients with HER2+ and TNBC with brain metastases
Gaia Griguolo • 21 Sep 2021
2:38
HER2+ and TNBC highlights from ESMO 2021
Gaia Griguolo • 21 Sep 2021
View All Videos
1:30
Results of the Phase II GeparNuevo trial
Evandro de Azambuja • 11 Jun 2021
3:01
Top news in breast cancer from ASCO 2021
Nadia Harbeck • 7 Jun 2021
2:58
OlympiA: adjuvant olaparib following chemo significantly improves IDFS
Evandro de Azambuja • 11 Jun 2021
4:03
Phase I/II trial of zenocutuzumab for tumors with NRG1 fusions
Alison M. Schram • 4 Jun 2021
View All Videos
3:22
PTEN protein and gene expression as a biomarker in breast cancer
Nicola Fusco • 13 May 2021
3:15
Brain metastases in HER2+ breast cancer
Volkar Mueller • 12 May 2021
4:46
TLR4 & pSTAT3 expression on CTCs in metastatic breast cancer
Maria Papadaki • 14 May 2021
1:20
CTCs, EMT & immunosuppresive cells in metastatic breast cancer
Maria Papadaki • 14 May 2021
View All Videos

The Breast Cancer Channel on VJOncology is supported by Gilead and Seagen.

These supporters have no influence over the production of the content.

If you are interested in becoming a supporter of The Breast Cancer Channel, please contact us.
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals